Liquivida Franchise Cost, Revenue & Review 2026
Data from FDD filing + SBA 7(a) records
Analysis by FranchiseVerdict Research · Methodology
Liquivida is a wellness franchise offering IV nutrient therapy, vitamin injections, and aesthetic treatments. Franchisees run the centers, managing clinical staff, appointments, and memberships.
FranchiseVerdict summary · 2026
A Liquivida franchise requires a total initial investment of $621K – $1.0M, including a $75K franchise fee and an ongoing 6.0% royalty[2]. Per the 2025 FDD, average unit revenue was $1.1M[2]. SBA 7(a) loans show a 0.0% charge-off rate across 15 loans[1]. FranchiseVerdict grade: B (Above average), an editorial assessment, not investment advice. Run a live ROI scan →
Data last verified · figures per the 2025 FDD issuance
Overview
- Investment
- $621K – $1.0M
- 74th pct Healthcare
- Avg gross sales
- $1.1M
- 19th pct Healthcare
- Royalty
- 6.0%
- 11th pct Healthcare
- Units
- 15
- 36th pct Healthcare
- SBA charge-off
- 0.0%
- % of SBA 7(a) loans not repaid · median varies by category
Quick verdict · Healthcare · color = vs category peers
Green = favorable by >10% vs Healthcare avg · No shading = within ±10% · Red = unfavorable by >10% · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Bottom line
- COSTTotal investment $621K – $1.0M including a $75K franchise fee, 6.0% ongoing royalty.
- RETURNSAverage unit revenue of $1.1M/year (median $926K).
- RISKVerdict B (Above average), verdict score 49/100 (higher is better). SBA loan charge-off rate of 0.0% across 15 loans (well below the franchise average, based on all SBA 7(a) franchise lending, 2010–2025).
- FLAGBankruptcy history disclosed in the FDD. Review Item 4 for details before proceeding.
Item 1 · who you're contracting with
The Franchisor
Corporate structure & franchisor financials
- Legal entity
- LQV Franchising LLC
- Parent company
- LQV Management
- Predecessor
- and Affiliates
- Prior franchisor entity
- CEO title
- Co-Founder / President
- Samael Tejada
- Incorporated in
- FL
- HQ
- 4901 NW 17th Way, Suite 305, Fort Lauderdale, FL 33309
- Auditor
- Assurance Dimensions
- Audited financials
- Franchisor revenue
- $899K
- vs $714K prior year
Independent franchisee associations
- Franchise Advisory Council (FAC)
Franchisee-led councils or alliances disclosed in Item 20. Indicates operator voice.
Affiliated brands
- Liquivita
- is LQV Health
Other brands the franchisor or its parent operates (Item 1).
Overview
About
- CEO
- Samael Tejada
- Headquarters
- FL
- Founded
- 2015
- FDD year
- 2025
- States available
- 4
Can you afford it, and what does the money buy?
Entry cost runs 98% above the typical healthcare franchise.
Source: FDD 2025 · Items 5–7
FDD Item 7 · 2025 filing
Initial investment breakdown
| Cost component | Low | High |
|---|---|---|
| Initial franchise fee | $75K | $75K |
| Working capital (3–6 mo) | $150K | $225K |
| Equipment, build-out, other | $396K | $725K |
| Total initial investment | $621K | $1.0M |
Source: Liquivida 2025 FDD, Items 5 and 7[2]. “Equipment, build-out, other” is computed as total minus disclosed line items above.
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $621K – $1.0M
- Bottom third — review vs category
- Liquid capital req'd
- $150K – $225K
- Bottom third — review vs category
- Franchise fee
- $75K – $75K
- Bottom third — review vs category
- Royalty
- 6.0%
- percentage · typical 6–8%
- Ad fund
- $1,500 per month flat (Brand Fund Contribution)
- Total fee load
- 6.0%
- vs 9–13% typical
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Royalty | 6.0% of gross sales |
| Technology fee | $500 |
| Transfer fee | $10K |
| Renewal fee | $10K |
| Inventory (initial) | $27K – $43K |
| Total fee load | 6.0% of rev |
A 6.0% total fee load is unusually lean. More of each revenue dollar stays with the franchisee.
What do units actually make?
Average unit sales run 20% below the healthcare norm.
Source: FDD 2025 · Item 19
Single-unit · estimated
Returns at a glance
Indicative numbers using FDD Item 7 / Item 19 inputs and category-benchmarked cost ratios. Full single-unit, 25-unit portfolio, and LBO models (with every input editable to stress-test your own scenario) live on the financials page.
Store EBITDA · annual
$180K
16.0% margin
Unlevered ROIC
18%
EBITDA / total invested capital
Payback
5.6 yrs
cash-on-cash, unlevered
ROI & LBO modelsSingle-unit · 25-unit portfolio · editable
What one unit earns on your invested capital
Model A · Single-Unit Return
Computes unlevered return on invested capital (ROIC) for a single franchise unit. The target band for an attractive franchise is 30–60% ROIC. Below that and a passive index fund likely outperforms; above that and the franchisor has pricing power you're subsidizing.
Note: Item 19 revenue is what the franchisor discloses. It's the top line only. Operating costs below are category estimates. Override them to match your real lease quote, labor market, and build-out budget.
Returns model · single-unit ROIC
What would one Liquivida unit return on the cash you put in?
Unlevered ROIC · per unit
Estimated return on your total franchise investment, before any debt financing.
18%
Below the 30–60% attractive-franchise band
What 25 units return when you use SBA financing
Model B · Return on Equity: Debt-Financed Acquisition
Models a 25-unit portfolio acquisition financed with an SBA 7(a) loan. Shows equity IRR (your return on cash invested), DSCR (how safely the cash flow covers debt service), and the capital stack (SBA + seller + equity breakdown).
This is the “search fund” or “entrepreneurship through acquisition” scenario: you buy an existing multi-unit operator, use leverage to amplify returns, and either operate or hire management. The 25-unit size is the typical minimum for an SBA-backed franchise portfolio acquisition to pencil as a full-time income.
What “return on equity” means here: if you put in $500K of your own cash and the business generates enough EBITDA to pay down debt and grow, your equity IRR is the annual return on that $500K, including the value created when you eventually sell. Target IRR for a search fund is typically 25–35%.
Levered LBO scenario · Yale Crease Capital framing
What would 25 Liquivida units return on equity?
Equity IRR · 5-yr
49.1%
7.37× MOIC
Year-1 DSCR
1.89×
EBITDA ÷ debt service
Equity required
$2.1M
on $10.1M purchase
Total debt
$8.0M
SBA $5.0M + senior + seller note
These models are for research and scenario planning only. Not investment advice. Actual results depend on your specific location, management, and market conditions. Consult a franchise attorney and accountant before signing any franchise agreement.
Item 19 · Source: 2025 FDD
Financial Performance
- Avg gross sales
- $1.1M
- Per unit, per year
- Median gross sales
- $926K
Gross sales are revenue before expenses — not profit. Actual owner earnings depend on rent, labor, royalties, marketing fees, and debt service.
- Item 19 type
- gross sales
- Sample size
- 9
- vs category median 20 · small
- Range (low → high)
- $251K→$2.7M
- Cohort dispersion (min → max)
- Reporting year
- 2024
- Fiscal year the figures cover
- Source filing
- FDD 2025
- Disclosed in the 2025 filing, covering 2024
- Transparency
- 4 / 10
- vs category median 3 / 10 · above
Compared against 162 Healthcare brands
Operator outlook
What the numbers say
Data-driven interpretation of this brand's financial disclosures, fee structure, and system trajectory.
Unit economics
Average unit generates $1.1M/year in gross sales. Median is $926K — top performers pull the average up, so a typical unit earns less. Revenue-to-investment ratio: 1.4x.
Fee burden
Total ongoing fee load of 6.0% — below the Healthcare average of 8.8%.
Disclosure
Transparency score 4/10 — this franchisor discloses detailed breakdowns (quartiles, segments, or cohort data). Buyers can model unit economics with higher confidence.
Operator retention
System expanding at 71.4% CAGR over 3 years across 15 units — operators are staying and new ones are joining.
Source: FDD Item 19 financial performance representations and publicly filed FDD data. Past performance is not indicative of future results. Verify all figures with the franchisor and current franchisees before making any investment decision.
vs Healthcare averages
How Liquivida Compares
Is the system healthy?
Source: FDD 2025 · Item 20
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 15
- Opened
- 2
- Last reporting year
- Closed
- 0
- Terminated
- 0
- Franchisor ended the franchise (per Item 20)
- Non-renewed
- 0
- Term expired, not renewed (per Item 20)
- Turnover rate
- 16.7%
- Company-owned
- 3
- Corporate units in the system
- % franchised
- 80%
- vs corporate-owned
- Net growth (3-yr)
- +71.4%
- Net unit change over 3 years
- 3-yr CAGR
- +71.4%
- Compounded over last 3 years
3-year detail · Item 20
- Opened (3yr)
- 2
- Closed (3yr)
- 1
- Terminated (3yr)
- 1
- Non-renewed (3yr)
- 0
- Transfers (3yr)
- 0
- Reacquired (3yr)
- 2
- Franchisor bought back
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 12 · 4 states reported
The Territory Map
FDD Item 12 reports the state count, but the specific list isn't in our current data. The map will appear once we re-extract from the FDD or enough franchisee contacts are available.
4
states with franchisees (per FDD Item 12)
Fast growth in a small system. Newer franchisors expanding quickly may not yet have the support infrastructure of larger systems.
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
- Total loans
- 15
- Loan volume
- $8.1M
- Median loan
- $541K
- average
- Charge-off rate
- 0.0%
- rates vary by category · see methodology
Historical SBA 7(a) lending data, not predictive of future performance. How SBA charge-off rates are calculated
- Repayment rate (PIF)
- N/A
- 5-yr charge-off
- N/A
- Loans approved 2021+
- Active lenders
- 7
- Defaults
- 0
Vintage analysis
Liquivida charge-off rate by loan vintage
Top lenders financing Liquivida franchisees
Showing 3 of 7 lenders. The full breakdown — every lender, state distribution, interest rates & risk ratings — is in the SBA Lending Report below.
Explore lender portfolios on Bank Reports or regional data on State Reports.
Premium insight
SBA Lending Report
Deep-dive into Liquivida's SBA lending history: lender network, geographic footprint, interest rates, and more.
SBA Lending Report
- Principal loss rate and NAICS industry benchmark
- 7 lenders with concentration factor
- Per-state charge-off rates across 5 states
- Startup risk premium and job creation velocity
Instant access. No subscription.
With a 0.0% charge-off rate across 15 loans, banks have historically viewed this brand favorably for lending.
What could kill this investment?
SBA loans charge off at 0.0% — 100% below the 16.0% national norm, i.e. lower lender-observed risk.
Source: SBA 7(a) FOIA · FDD Items 3, 21
Risk analysis
FranchiseVerdict rating + FDD Items 3, 4, 8, 16, 21
Risk & Legal
Liquivida presents caution-level risk due to undisclosed profitability, franchisor going concern issues, litigation history, and a small, slowly-growing franchise system that raises sustainability questions.
Litigation (Item 3)
Two related cases involving the same terminated franchisee (Todaro Bro, Inc.): (1) LQV v. Todaro Bro - franchisor filed lawsuit for trademark infringement and non-compete violations, settled for $510,000 paid by franchisee; (2) Todaro Bro v. LQV - franchisee filed arbitration alleging misrepresentation of investment costs and tortious interference; franchisor prevailed and was awarded $446,000+ in damages, settled globally for $510,000.
Largest disclosed settlement: $510,000
Bankruptcy (Item 4)
Disclosed in last 7 years
Jeff Cogswell, Director of Franchise Sales, filed personal Chapter 7 bankruptcy in 2017 (Case No. 17-12326-JKO, S.D. Fla.); debts discharged March 16, 2018.
Audited financials (Item 21)
Yes · Assurance Dimensions
Franchisor revenue (Item 21)
Franchisor entity revenue (not unit-level)
Supplier relationship · Items 8 & 16
- Franchisor sells you products: Yes
- Kickbacks from required suppliers: Yes
- Must buy proprietary products: Yes
- Restricted to system-approved products: Yes
- Can negotiate own supplier terms: No
Score breakdown · what drove the 49 / 100 verdict
- 01HIGHGoing Concern status is False, indicating potential financial instability at franchisor level
- 02HIGHSignificant litigation history with trademark enforcement and breach of contract allegations affecting franchisee confidence
- 03MEDNet income not disclosed despite $1.124M average revenue, making ROI projections impossible to validate
- 04MINOROnly 15 units with 20% YoY growth is modest for a wellness/IV therapy concept; small system increases franchisor risk
Severity inferred from the FDD text · not a regulatory classification
What are you signing up for?
Ongoing fees run about 6.0% of sales (royalty + ad fund), before rent and labor.
Source: FDD 2025 · Items 11, 12, 17
FDD Items 12, 15, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 10 years |
|---|---|
| Renewal term | 5 years |
| Allowed renewalsℹ | 2 |
| Territory type | protected |
| Protected territory | Yes |
| Exclusive territoryℹ | No |
| Territory radius | 3 mi |
| Online sales rightsℹ | Restricted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Optional |
| Non-compete (years)ℹ | 2 years |
| Non-compete (miles)ℹ | 25 mi |
| Right of first refusalℹ | Yes |
| Transfer requires consent | Yes |
| Termination notice | 30 days |
| Termination groundsℹ | 2 |
| Curable defaultsℹ | 3 |
| Mandatory arbitration | Yes |
| Arbitration location | Broward County, Florida |
| Jury trial waiver | Yes |
| Governing law | FL |
| Litigation count | 2 |
View Item 3 litigation summary
Two related cases involving the same terminated franchisee (Todaro Bro, Inc.): (1) LQV v. Todaro Bro - franchisor filed lawsuit for trademark infringement and non-compete violations, settled for $510,000 paid by franchisee; (2) Todaro Bro v. LQV - franchisee filed arbitration alleging misrepresentation of investment costs and tortious interference; franchisor prevailed and was awarded $446,000+ in damages, settled globally for $510,000.
Items 10, 11
Training & Operations
- Classroom training
- 28 hrs
- On-the-job training
- 40 hrs
- Training location
- Corporate Headquarters, online or designated location
- Ongoing training
- Required
- Time to open
- 9 mo
- From signing to launch
- Site selection
- Franchisee selects; franchisor approves
- Franchisor financing
- Offered
- Item 10
- POS system
- Zenoti
- Operating tech stack
Items 5 & 11
Franchisor Support
Technology: Zenoti
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a Liquivida franchise?
The total investment to open a Liquivida franchise ranges from $621K – $1.0M, with an initial franchise fee of $75K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do Liquivida franchise owners earn?
According to Item 19 of the Liquivida FDD, the average gross sales per unit is $1.1M. The median is $926K. Note: this is gross revenue, not profit. Actual owner earnings vary based on location, operating costs, and management.
What is Item 19 in the Liquivida FDD?
The FDD section where a franchisor may disclose financial performance of its outlets. Disclosure is optional and formats vary; figures are typically gross sales, which is revenue before expenses, not profit. FranchiseVerdict extracts these figures directly from the Liquivida FDD and qualifies whose outlets they describe.
What is Liquivida's franchise failure rate?
Based on SBA 7(a) loan data, Liquivida has a charge-off rate of 0.0% across 15 loans, meaning 0.0% of franchise loans were charged off. Charge-off rates are one proxy for franchise risk, though they do not capture all closures. This data comes from FOIA-sourced SBA lending records.
How many Liquivida franchise locations are there?
As of their most recent FDD filing, Liquivida has 15 total units in the United States, including 12 franchised units and 3 company-owned units. 2 new units were opened in the latest reporting year.
Is Liquivida a good franchise to buy?
FranchiseVerdict rates Liquivida as a B-grade franchise with a verdict score of 49 out of 100 (higher is better), based on our analysis of investment costs, revenue data, SBA loan performance, and growth trends. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent Liquivida, you can request corrections or provide updated information.
Other Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.